Albusol
No structure available
This product's active ingredient could not be matched to a single known compound.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| National bioproducts institute | Albusol | 4 %, 20 % | T0738, T0739 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Albusol 4 % EACH 100 ml SOLUTION CONTAINS IMMUNOGLOBULIN HUMAN NORMAL 4 g | 4 % | T0738T/30.3/738 | Registered | Not determined | None |
| Albusol 20 % EACH 1 ml SOLUTION CONTAINS IMMUNOGLOBULIN HUMAN NORMAL 0,20 g | 20 % | T0739T/30.3/739 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.